<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-TNV5PS3" height="0" width="0" style="display:none;visibility:hidden">

Abstracts & Posters

Blood Cell-Free DNA (cfDNA) Analysis for Diagnosis of Infections and Outcomes in the Pediatric ICU
Presenting Center: Driscoll Children's Hospital

Sunday, January 22 I 2:15 - 3:15 pm PT I Exhibit Hall - RST 10

Cell-Free DNA Testing for Early Diagnosis of Tuberculous Meningitis in Critically Ill Children
Presenting Center: Driscoll Children's Hospital

Monday, January 23 I 12 - 1 pm PT I Exhibit Hall - RST 12

Stay up-to-date with Karius

Sign up today to receive notification of future real-world cases of the Karius Test being used by physicians and upcoming events.


What is the Karius Test?

The Karius Test is a non-invasive liquid biopsy needing only a single blood sample to rapidly detect over 1,000 pathogens causing both deep-seated and bloodstream infections.
1 blood sample
Vector Smart Object (1)
1-day processing
Vector Smart Object (2)
1000+ pathogens

*The Karius Test® was developed and its performance characteristics determined by Karius. This test has not been cleared or approved by the FDA, nor is it required to be. The Karius laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA ’88) and is accredited by the College of American Pathologists (CAP) to perform high-complexity clinical laboratory testing.